Clinical Trial: Wise Practice of Chinese Hemodialysis (WISHES)

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]

Official Title: Wise Practice of Chinese Hemodialysis (WISHES)

Brief Summary: The investigators are registering all HD patients at recruited hospitals and developing a HD database in China. Patients will be follow-up every 3 months, and both baseline and follow-up information will be entered into the registration system. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.

Detailed Summary: The investigators are registering all end stage renal disease (ESRD) patients receiving hemodialysis (HD) treatment, and developing a HD database in China. Patients' demographic characteristics (including age, gender, height, weight, BMI, smoking, drinking, and education), clinical characteristics (including systolic blood pressure, diastolic blood pressure, primary cause of ESRD, and lab measurements of serum, urine, and access patency), complications, drug information and scores of quality of life at the baseline will be collected. Patients will be follow-up every 3 month, the demographic and clinical characteristics, complications and drug information of patients will be collected at each visit. The investigators also record the outcome at each visit, such as mortality (including all-cause mortality and cardiovascular disease mortality), technical survival, kidney transplantation, transfer to peritoneal dialysis, hospitalization, access failure，etc. The patient survival, technical survival, patency rate of access, quality of life and residual renal function for HD patients will be compared using the HD database.
Sponsor: Sun Yat-sen University

Current Primary Outcome: Patient survival of HD patients [ Time Frame: 10 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Quality of life evaluated using SF36 scale for HD patients [ Time Frame: 10 years ]
  • Patency rate of access for HD patients [ Time Frame: 10 years ]


Original Secondary Outcome:

  • Quality of life for HD patients [ Time Frame: 10 years ]
  • Patency rate of access for HD patients [ Time Frame: 10 years ]


Information By: Sun Yat-sen University

Dates:
Date Received: December 21, 2016
Date Started: December 2013
Date Completion: December 2027
Last Updated: December 23, 2016
Last Verified: December 2016